1. Home
  2. PIPR vs GRFS Comparison

PIPR vs GRFS Comparison

Compare PIPR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

N/A

Current Price

$65.50

Market Cap

5.5B

Sector

Finance

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$7.48

Market Cap

4.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PIPR
GRFS
Founded
1895
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.9B
IPO Year
2003
2008

Fundamental Metrics

Financial Performance
Metric
PIPR
GRFS
Price
$65.50
$7.48
Analyst Decision
Buy
Buy
Analyst Count
5
2
Target Price
★ $80.88
$10.87
AVG Volume (30 Days)
★ 700.5K
429.1K
Earning Date
10-30-2026
07-28-2022
Dividend Yield
★ 3.18%
1.16%
EPS Growth
★ 54.49
N/A
EPS
★ 1.87
N/A
Revenue
★ $1,904,217,000.00
N/A
Revenue This Year
$9.70
$1.73
Revenue Next Year
$12.44
$6.26
P/E Ratio
$34.43
★ $18.67
Revenue Growth
★ 24.33
N/A
52 Week Low
$62.69
$6.96
52 Week High
$380.26
$9.90

Technical Indicators

Market Signals
Indicator
PIPR
GRFS
Relative Strength Index (RSI) 34.67 50.11
Support Level N/A $7.44
Resistance Level $77.95 $8.36
Average True Range (ATR) 2.37 0.13
MACD -0.41 0.03
Stochastic Oscillator 21.68 79.52

Price Performance

Historical Comparison
PIPR
GRFS

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: